ES2684437B1 - Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez - Google Patents

Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez Download PDF

Info

Publication number
ES2684437B1
ES2684437B1 ES201730468A ES201730468A ES2684437B1 ES 2684437 B1 ES2684437 B1 ES 2684437B1 ES 201730468 A ES201730468 A ES 201730468A ES 201730468 A ES201730468 A ES 201730468A ES 2684437 B1 ES2684437 B1 ES 2684437B1
Authority
ES
Spain
Prior art keywords
heartburn
drug
prepare
treatment
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201730468A
Other languages
English (en)
Other versions
ES2684437A1 (es
Inventor
De Vicente Manuel Mateos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES201730468A priority Critical patent/ES2684437B1/es
Publication of ES2684437A1 publication Critical patent/ES2684437A1/es
Application granted granted Critical
Publication of ES2684437B1 publication Critical patent/ES2684437B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES201730468A 2017-03-29 2017-03-29 Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez Expired - Fee Related ES2684437B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201730468A ES2684437B1 (es) 2017-03-29 2017-03-29 Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201730468A ES2684437B1 (es) 2017-03-29 2017-03-29 Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez

Publications (2)

Publication Number Publication Date
ES2684437A1 ES2684437A1 (es) 2018-10-02
ES2684437B1 true ES2684437B1 (es) 2019-08-22

Family

ID=63668604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201730468A Expired - Fee Related ES2684437B1 (es) 2017-03-29 2017-03-29 Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez

Country Status (1)

Country Link
ES (1) ES2684437B1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2806880T (lt) * 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
US20140255465A1 (en) * 2013-03-08 2014-09-11 Cognate3 Llc Process For The Preparation Of A Non-Corrosive Base Solution And Methods Of Using Same
CN103845734A (zh) * 2014-03-20 2014-06-11 辽宁亿灵科创生物医药科技有限公司 埃索美拉唑药物组合物及其制剂

Also Published As

Publication number Publication date
ES2684437A1 (es) 2018-10-02

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
GB201807942D0 (en) Pharmaceutical formulation
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
BR112016022062A2 (pt) Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico
BR112016021034A2 (pt) Composição farmacêutica, uso de tal composição, método para tratar uma doença e kit
ES2970485T3 (es) Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares
DK3634377T3 (da) Farmaceutisk formulering
DK3168214T3 (da) Substituerede 2-thioxo-imidazolidin-4-oner og spiro- analoger deraf, aktiv anti-canceringrediens, farmaceutisk sammensætning, medicinpræparat, fremgangsmåde til behandling af prostatacancer
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
SG11202010124SA (en) Stable pharmaceutical formulation
IL276323A (en) 4-Methyldihydropyrimidinone compounds and their pharmaceutical use
BR112016026470A2 (pt) Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto
HK1250147A1 (zh) 一種凍干藥物製劑及其用途
DK3601277T3 (da) Farmaceutisk formulering
ES2684437B1 (es) Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez
IL275144A (en) Pharmacy preparation
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
DK3153163T3 (da) Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf
HK1254527A1 (zh) 藥物調配物和其用途
GB201719873D0 (en) Pharmaceutical formulation
GB201901924D0 (en) Herbal oil formulation for tropical use and medicinal applications thereof

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2684437

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20181002

FG2A Definitive protection

Ref document number: 2684437

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20190822

FD2A Announcement of lapse in spain

Effective date: 20211004